GSK’s Blenrep gains approval in Japan for advanced multiple myeloma
The approval is based on the findings of the DREAMM-7 and DREAMM-8 trials, which assessed Blenrep with BVd and BPd in patients previously treated at least once

A leading resource for the Pharmaceutical industry since 2002
The approval is based on the findings of the DREAMM-7 and DREAMM-8 trials, which assessed Blenrep with BVd and BPd in patients previously treated at least once
Give your business an edge with our leading industry insights.
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry